Benralizumab

Category: Asthma



Benralizumab Overview

Benralizumab, sold under the brand name Fasenra, is a monoclonal antibody medication which is developed by MedImmune for the treatment of asthma. It is directed against the alpha-chain of the interleukin-5 receptor (CD125).[2][3] Two phase III clinical trials of benralizumab reported meeting their primary endpoints in 2016.[4][5] It was approved by the US Food and Drug Administration in November 2017 for the treatment of severe e...

Read more Benralizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Benralizumab

Recent Benralizumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Benralizumab
  • Injection: 30mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Benralizumab or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 30 July 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA